GO Term |
---|
alphav-beta3 integrin-IGF-1-IGF1R complex |
protein kinase complex |
plasma membrane |
membrane |
axon |
neuronal cell body |
intracellular membrane-bounded organelle |
receptor complex |
T-tubule |
insulin receptor complex |
GO Term |
---|
positive regulation of DNA metabolic process |
positive regulation of steroid hormone biosynthetic process |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
51 | N-linked (GlcNAc...) asparagine |
|
||
102 | N-linked (GlcNAc...) asparagine |
|
||
135 | N-linked (GlcNAc...) asparagine |
|
||
244 | N-linked (GlcNAc...) asparagine | |||
314 | N-linked (GlcNAc...) asparagine |
|
||
417 | N-linked (GlcNAc...) asparagine |
|
||
438 | N-linked (GlcNAc...) asparagine |
|
||
534 | N-linked (GlcNAc...) asparagine |
|
||
607 | N-linked (GlcNAc...) asparagine | |||
622 | N-linked (GlcNAc...) asparagine |
Pathway Name | Organism |
---|---|
Extra-nuclear estrogen signaling | Homo sapiens |
IRS-related events triggered by IGF1R | Homo sapiens |
Respiratory syncytial virus (RSV) attachment and entry | Homo sapiens |
SHC-related events triggered by IGF1R | Homo sapiens |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:11476 | osteoporosis | |
DOID:11695 | portal vein thrombosis | |
DOID:12217 | Lewy body dementia | |
DOID:1307 | dementia | |
DOID:1793 | pancreatic cancer | |
DOID:2154 | nephroblastoma | |
DOID:2526 | prostate adenocarcinoma | |
DOID:2986 | IgA glomerulonephritis | |
DOID:3070 | high grade glioma | |
DOID:3602 | toxic encephalopathy |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025